Ligand Pharmaceuticals Incorporated ( LGND) - Stock Earnings
LGND Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
LGND Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 44.8 million USD | 59.7 million USD |
| 2026Q1 | -13.3 million USD | 51.7 million USD |
| 2026Q2 | 48.5 million USD | 63.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LGND Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 52.2 million USD | 131.3 million USD |
| 2024 | -4.0 million USD | 167.1 million USD |
| 2025 | 124.5 million USD | 268.1 million USD |
| 2026 Est. | — | — |
LGND
Price: $294.99
Earnings Per Share: 9.87 USD
P/E Ratio: 29.71
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 186100
Ebitda: 19.2 millionMarket Capitalization: 6.1 billion